Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • china cas 85815-37-8 rilmazafone hydrochloride

Nov . 22, 2024 15:30 Back to list

china cas 85815-37-8 rilmazafone hydrochloride



Understanding Rilmazafone Hydrochloride An Overview of CAS 85815-37-8


Rilmazafone hydrochloride, identified by its Chemical Abstracts Service (CAS) number 85815-37-8, is a compound that has garnered significant attention in pharmacological and clinical research. As a derivative in the class of compounds known for their psychoactive properties, Rilmazafone has been investigated primarily for its potential utility in treating insomnia and other sleep-related disorders.


Chemical Structure and Properties


Rilmazafone hydrochloride is a synthetic compound characterized by its unique chemical structure which allows it to interact with specific neuroreceptors in the brain. The chemical formula of Rilmazafone is C19H23ClN2O2S, and it features a thiazole ring, which is a common motif in many pharmacologically active compounds. Understanding the molecular intricacies of Rilmazafone is essential for comprehending its mechanism of action as a sleep aid.


Mechanism of Action

The primary mechanism by which Rilmazafone exerts its effects involves modulation of neurotransmitter systems in the central nervous system. Specifically, it is known to enhance the activity of gamma-aminobutyric acid (GABA), a chief inhibitory neurotransmitter in the brain. By facilitating GABAergic activity, Rilmazafone promotes an anxiolytic (anxiety-reducing) and sedative effect, making it beneficial for individuals suffering from sleep disturbances.


Therapeutic Applications


Rilmazafone hydrochloride has shown promise in clinical settings for the treatment of insomnia. Insomnia, characterized by difficulty in sleeping or maintaining sleep, poses significant challenges to individuals' health and well-being. The sedative properties of Rilmazafone offer a potential pathway to improve sleep latency and overall sleep quality, addressing the root causes of insomnia rather than merely alleviating symptoms.


china cas 85815-37-8 rilmazafone hydrochloride

china cas 85815-37-8 rilmazafone hydrochloride

Moreover, the drug's favorable side effect profile, particularly its lower risk of dependence compared to traditional benzodiazepines, makes it an attractive option for long-term management of sleep disorders. Studies have indicated that patients using Rilmazafone experience improvements in sleep architecture, promoting longer durations of deep sleep and reducing nighttime awakenings.


Research and Development


Ongoing research into Rilmazafone hydrochloride continues to expand its therapeutic implications. Current studies are focusing on understanding its long-term effects, efficacy in diverse populations, and potential applications in related areas such as anxiety and depression. There is also a keen interest in exploring its use in elderly populations who are particularly vulnerable to sleep disorders.


Safety and Side Effects


As with any pharmacological agent, understanding the safety profile of Rilmazafone is crucial. Clinical trials have revealed that Rilmazafone is generally well-tolerated, with side effects being mild to moderate in nature. Commonly reported side effects include drowsiness, dizziness, and occasional gastrointestinal discomfort. Importantly, due to its specific action on GABA receptors, there is a lower likelihood of developing tolerance or physical dependence, highlighting its therapeutic advantage.


Conclusion


In conclusion, Rilmazafone hydrochloride (CAS 85815-37-8) represents a significant advancement in the management of sleep disorders, particularly insomnia. Its unique mechanism of action, coupled with a favorable safety profile, makes it a valuable candidate for both acute and chronic treatment strategies. As research continues to unfold, further insights into its efficacy and application may solidify Rilmazafone's role in modern pharmacotherapy for sleep-related issues. The growing interest in its potential benefits indicates a promising future for both patients and medical professionals seeking effective solutions to sleep disorders.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish